# Single-ascending Dose Study of HEC-151 Injection

> **NCT07376200** · PHASE1 · RECRUITING · sponsor: **Sunshine Lake Pharma Co., Ltd.** · enrollment: 81 (estimated)

## Conditions studied

- Healthy Adult Male

## Interventions

- **DRUG:** HEC-151 Injection
- **DRUG:** Degludec insulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07376200
- **Lead sponsor:** Sunshine Lake Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2026-09-05
- **Final completion:** 2026-09-27
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07376200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07376200, "Single-ascending Dose Study of HEC-151 Injection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07376200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*